Logo image of ZJYL

JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Fundamental Analysis

NASDAQ:ZJYL - Nasdaq - KYG5140V1124 - Common Stock - Currency: USD

0.7639  -0.03 (-3.79%)

After market: 0.77 +0.01 (+0.8%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ZJYL. ZJYL was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While ZJYL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ZJYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ZJYL had positive earnings in the past year.
In the past year ZJYL had a positive cash flow from operations.
In the past 5 years ZJYL has always been profitable.
ZJYL had a positive operating cash flow in 4 of the past 5 years.
ZJYL Yearly Net Income VS EBIT VS OCF VS FCFZJYL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

1.2 Ratios

With an excellent Return On Assets value of 7.06%, ZJYL belongs to the best of the industry, outperforming 88.83% of the companies in the same industry.
ZJYL has a better Return On Equity (11.07%) than 85.64% of its industry peers.
ZJYL has a Return On Invested Capital of 5.10%. This is in the better half of the industry: ZJYL outperforms 78.19% of its industry peers.
ZJYL had an Average Return On Invested Capital over the past 3 years of 11.31%. This is above the industry average of 8.22%.
The 3 year average ROIC (11.31%) for ZJYL is well above the current ROIC(5.10%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.06%
ROE 11.07%
ROIC 5.1%
ROA(3y)11.23%
ROA(5y)12.44%
ROE(3y)16.18%
ROE(5y)20.61%
ROIC(3y)11.31%
ROIC(5y)14.68%
ZJYL Yearly ROA, ROE, ROICZJYL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 14.44%, ZJYL belongs to the top of the industry, outperforming 92.02% of the companies in the same industry.
ZJYL's Profit Margin has declined in the last couple of years.
ZJYL's Operating Margin of 11.55% is fine compared to the rest of the industry. ZJYL outperforms 79.79% of its industry peers.
In the last couple of years the Operating Margin of ZJYL has declined.
ZJYL's Gross Margin of 34.73% is on the low side compared to the rest of the industry. ZJYL is outperformed by 71.28% of its industry peers.
In the last couple of years the Gross Margin of ZJYL has remained more or less at the same level.
Industry RankSector Rank
OM 11.55%
PM (TTM) 14.44%
GM 34.73%
OM growth 3Y-0.18%
OM growth 5Y-6.48%
PM growth 3Y2.15%
PM growth 5Y-3.78%
GM growth 3Y0.27%
GM growth 5Y-1.34%
ZJYL Yearly Profit, Operating, Gross MarginsZJYL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZJYL is still creating some value.
ZJYL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ZJYL has been reduced compared to 5 years ago.
The debt/assets ratio for ZJYL is higher compared to a year ago.
ZJYL Yearly Shares OutstandingZJYL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M 150M
ZJYL Yearly Total Debt VS Total AssetsZJYL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ZJYL has an Altman-Z score of 6.87. This indicates that ZJYL is financially healthy and has little risk of bankruptcy at the moment.
ZJYL has a Altman-Z score of 6.87. This is amongst the best in the industry. ZJYL outperforms 85.11% of its industry peers.
ZJYL has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
ZJYL has a Debt to Equity ratio (0.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 6.87
ROIC/WACC0.69
WACC7.42%
ZJYL Yearly LT Debt VS Equity VS FCFZJYL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

ZJYL has a Current Ratio of 2.58. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.58, ZJYL perfoms like the industry average, outperforming 46.81% of the companies in the same industry.
ZJYL has a Quick Ratio of 2.27. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
ZJYL's Quick ratio of 2.27 is in line compared to the rest of the industry. ZJYL outperforms 53.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.27
ZJYL Yearly Current Assets VS Current LiabilitesZJYL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

ZJYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.83%.
ZJYL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.87% yearly.
The Revenue for ZJYL has decreased by -31.65% in the past year. This is quite bad
ZJYL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.07% yearly.
EPS 1Y (TTM)-37.83%
EPS 3Y25.99%
EPS 5Y14.87%
EPS Q2Q%-12.17%
Revenue 1Y (TTM)-31.65%
Revenue growth 3Y6.97%
Revenue growth 5Y-1.07%
Sales Q2Q%2.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZJYL Yearly Revenue VS EstimatesZJYL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ZJYL Yearly EPS VS EstimatesZJYL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.20, the valuation of ZJYL can be described as expensive.
Based on the Price/Earnings ratio, ZJYL is valued a bit cheaper than the industry average as 70.74% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.62. ZJYL is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 38.2
Fwd PE N/A
ZJYL Price Earnings VS Forward Price EarningsZJYL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZJYL is valued a bit cheaper than 70.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.92
ZJYL Per share dataZJYL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

ZJYL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.57
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZJYL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (2/21/2025, 8:00:02 PM)

After market: 0.77 +0.01 (+0.8%)

0.7639

-0.03 (-3.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.23%
Inst Owner Change-100%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.59M
AnalystsN/A
Price TargetN/A
Short Float %2.17%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.2
Fwd PE N/A
P/S 5.94
P/FCF N/A
P/OCF 289.63
P/B 4.56
P/tB 4.76
EV/EBITDA 29.92
EPS(TTM)0.02
EY2.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY0.35%
SpS0.13
BVpS0.17
TBVpS0.16
PEG (NY)N/A
PEG (5Y)2.57
Profitability
Industry RankSector Rank
ROA 7.06%
ROE 11.07%
ROCE 8.83%
ROIC 5.1%
ROICexc 18.32%
ROICexgc 20.63%
OM 11.55%
PM (TTM) 14.44%
GM 34.73%
FCFM N/A
ROA(3y)11.23%
ROA(5y)12.44%
ROE(3y)16.18%
ROE(5y)20.61%
ROIC(3y)11.31%
ROIC(5y)14.68%
ROICexc(3y)21.85%
ROICexc(5y)23.41%
ROICexgc(3y)22.27%
ROICexgc(5y)23.85%
ROCE(3y)14.9%
ROCE(5y)21.53%
ROICexcg growth 3Y4.14%
ROICexcg growth 5Y-15.67%
ROICexc growth 3Y4.27%
ROICexc growth 5Y-15.45%
OM growth 3Y-0.18%
OM growth 5Y-6.48%
PM growth 3Y2.15%
PM growth 5Y-3.78%
GM growth 3Y0.27%
GM growth 5Y-1.34%
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 3.79
Cap/Depr 504.33%
Cap/Sales 5.8%
Interest Coverage 250
Cash Conversion 16.15%
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.27
Altman-Z 6.87
F-Score4
WACC7.42%
ROIC/WACC0.69
Cap/Depr(3y)24.63%
Cap/Depr(5y)25.62%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.41%
Profit Quality(3y)127.09%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.83%
EPS 3Y25.99%
EPS 5Y14.87%
EPS Q2Q%-12.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.65%
Revenue growth 3Y6.97%
Revenue growth 5Y-1.07%
Sales Q2Q%2.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.41%
EBIT growth 3Y6.78%
EBIT growth 5Y-7.48%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-139.11%
FCF growth 3Y8.22%
FCF growth 5YN/A
OCF growth 1Y-79.02%
OCF growth 3Y7.46%
OCF growth 5YN/A